Solution Microarrays Using Aqueous Two-Phase Systems
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing diagnostic assays lack sufficient sensitivity and specificity, particularly in detecting analytes at low concentrations in complex biological samples, and are often expensive and inefficient.
Innovation Solution
An aqueous two-phase system comprising polymers such as polyethylene glycol (PEG), polyvinyl alcohol (PVA), and hydroxypropyl dextran (HPD) is used to create solution microarrays, where a first solution with detection reagents and a second solution with the test sample form a system that enhances sensitivity and specificity through the use of antibodies and detection methods like fluorescence resonance energy transfer.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional ELISA assays are used for analyte detection, then the assay can be performed with simple methodology, but the sensitivity and specificity are insufficient and costs are high
Solution Approach 1:
The assay system is segmented into distinct functional components: solution microarrays with spatially separated analyte spots, phase-separated aqueous two-phase systems for selective partitioning, and modular detection reagents. This segmentation enables high sensitivity and specificity through controlled interactions while maintaining manageable complexity through standardized components.
Solution Approach 2:
The patent introduces intermediary elements including aqueous two-phase systems that mediate selective partitioning of analytes, microarray substrates that mediate spatial organization, and detection reagents that mediate signal generation. These intermediaries enhance measurement precision without requiring complex direct detection methodologies.
2Measurement precision
If detection reagents are used to improve analyte detection, then sensitivity increases, but reagent costs and cross-reactivity issues increase
Solution Approach 1:
Detection reagents are applied locally to specific microarray spots rather than uniformly across the entire sample. Each spot contains reagents specific to that analyte, enabling targeted detection that reduces overall reagent consumption and minimizes cross-reactivity while maintaining high sensitivity at each detection location.
Solution Approach 2:
The patent extracts and separates detection functions into discrete, reusable components including phase-separated reagent systems and spot-specific antibodies. This extraction allows reagents to be optimized for specific analytes, reducing cross-reactivity and enabling cost-effective reuse of detection components across multiple assays.
3Loss of information
If complex biological samples are analyzed for low concentration analytes, then diagnostic information is obtained, but sample complexity and detection difficulty increase
Solution Approach 1:
The patent transitions from conventional two-dimensional planar assays to three-dimensional solution microarrays with vertical phase separation. Analytes partition into different aqueous phases based on their properties, adding a dimensional separation mechanism that simplifies detection of low-concentration analytes in complex samples by spatially isolating them from interfering substances.
Solution Approach 2:
The system exploits changes in physical parameters including phase partitioning coefficients, viscosity differences between aqueous phases, and concentration gradients to enhance analyte detection. These parameter changes enable selective enrichment of low-concentration analytes from complex matrices, reducing detection difficulty while preserving diagnostic information.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly improves the sensitivity of assays, allowing for the detection of analytes at nanogram per milliliter concentrations with reduced reagent usage and costs, while minimizing cross-reactivity in multiplex assays.
Implementation Method 1
a second solution comprising a second polymer and the test sample, wherein the second solution has a different density (e.g., more or less dense) than the first solution, and wherein the first and second solutions form an aqueous two-phase system when mixed
Implementation Method 2
The reagents comprise an antibody that specifically binds to the analyte (e.g., an antigen)
Implementation Method 3
detection methods like fluorescence resonance energy transfer
Data Source
AI summary
The present invention relates to solution microarrays. In particular, the present invention relates to an aqueous 2-phase system for solution microarrays and uses thereof. The present invention further relates to systems and methods for performing assays within the solution microarrays (e.g., diagnostic assays).